BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8814693)

  • 21. Photopenic lesions in bone scintigraphy.
    Goris ML; Basso LV; Etcubanas E
    Clin Nucl Med; 1980 Jul; 5(7):299-301. PubMed ID: 6930338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone metastases in osteosarcoma patients treated with neoadjuvant or adjuvant chemotherapy: the Rizzoli experience in 52 patients.
    Bacci G; Longhi A; Bertoni F; Briccoli A; Versari M; Pignotti E; Picci P
    Acta Orthop; 2006 Dec; 77(6):938-43. PubMed ID: 17260205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone scintigraphy in breast cancer: a ten-year follow-up study.
    Crippa F; Seregni E; Agresti R; Bombardieri E; Buraggi GL
    J Nucl Biol Med (1991); 1993 Jun; 37(2):57-61. PubMed ID: 8373834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Scintigraphy with 99mTc-phosphonate and 67gallium in patients suspected of primary bone tumors.
    Edeling CJ
    Nuklearmedizin; 1982 Aug; 21(4):136-9. PubMed ID: 6959075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recurrence behavior in early-stage cutaneous melanoma: pattern, timing, survival, and influencing factors.
    Tas F; Erturk K
    Melanoma Res; 2017 Apr; 27(2):134-139. PubMed ID: 28099368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone scintigraphy in patients with osteogenic sarcoma. Cooperative Osteogenic Sarcoma Study Group COSS 80.
    Knop J; Montz R
    J Cancer Res Clin Oncol; 1983; 106 Suppl():49-50. PubMed ID: 6577015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone scanning in management of metastatic osteogenic sarcoma.
    Siddiqui AR; Wellman HN; Weetman RM; Smith WL
    Clin Nucl Med; 1979 Jan; 4(1):6-11. PubMed ID: 283899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Technetium-99m-tetrofosmin whole-body scintigraphy in the follow-up of differentiated thyroid carcinoma.
    Lind P; Gallowitsch HJ; Langsteger W; Kresnik E; Mikosch P; Gomez I
    J Nucl Med; 1997 Mar; 38(3):348-52. PubMed ID: 9074515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rationale for the use of bone scans in selected metastatic and primary bone tumors.
    McNeil BJ
    Semin Nucl Med; 1978 Oct; 8(4):336-45. PubMed ID: 112684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The significance of surveillance imaging in children with Ewing sarcoma and osteosarcoma.
    Brekke SG; Lucke A; Hasle H; Baad-Hansen T
    Pediatr Hematol Oncol; 2024 May; 41(4):273-282. PubMed ID: 38345039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evaluation of recurrence of musculoskeletal tumors with thallium-201 scintigraphy plus SPECT/CT in pediatric population].
    Medina-Ornelas SS; Vera-Hermosillo H; Delgado-Espín R; García-Pérez FO
    Bol Med Hosp Infant Mex; 2018; 75(1):31-40. PubMed ID: 29652875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone scan appearance in aggressive osteogenic sarcoma with pleural, lung, bone, and soft-tissue metastases.
    Othman S; El-Desouki M
    Clin Nucl Med; 2003 Nov; 28(11):926. PubMed ID: 14578712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic relapse of patients with osteogenic sarcoma. Prognostic factors for long term survival.
    Saeter G; Høie J; Stenwig AE; Johansson AK; Hannisdal E; Solheim OP
    Cancer; 1995 Mar; 75(5):1084-93. PubMed ID: 7850705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone metastases in primary operable breast cancer. The role of a yearly scintigraphy.
    Thomsen HS; Rasmussen D; Munck O; Lund JO; Gerhard-Nielsen V; Terkildsen T; Dombernowsky P; Andersen KW
    Eur J Cancer Clin Oncol; 1987 Jun; 23(6):779-81. PubMed ID: 3115785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
    Lind P; Gallowitsch HJ
    Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The value of radionuclide bone imaging in selected patients with osteogenic sarcoma metastatic to lung.
    Kirks DR; McCook TA; Merten DF; Sullivan DC
    Pediatr Radiol; 1980 Apr; 9(3):139-43. PubMed ID: 6930625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radionuclide detection of multiple soft tissue metastases of osteosarcoma masquerading as bone metastasis.
    Takesh M; Zoller H; Ghazi H; Zein M; Sahli H
    Med Princ Pract; 2012; 21(6):582-4. PubMed ID: 22699859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of
    Angelini A; Ceci F; Castellucci P; Graziani T; Polverari G; Trovarelli G; Palmerini E; Ferrari S; Fanti S; Ruggieri P
    Eur J Nucl Med Mol Imaging; 2017 Sep; 44(10):1712-1720. PubMed ID: 28405727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. "Bubble-like" lung metastases in osteosarcoma patients.
    Briccoli A; Rocca M; Salone MC; Di Fiore M; Vanel D; Balladelli A; Alberghini M
    Eur J Radiol; 2009 Jul; 71(1):144-6. PubMed ID: 18406558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current status of bone scintigraphy in the diagnosis and treatment of osteogenic sarcoma.
    Zwas ST
    Prog Clin Biol Res; 1982; 99():43-8. PubMed ID: 6959161
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.